Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Clinical trial NCT06311851 · RECRUITING
Trial details
- NCT number
- NCT06311851
- Sponsor
- Pardis Noor Medical Imaging and Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-03-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.